Sonendo, Inc. (SONX) |
|
1.82 0.02 (1.11%)
|
03-24 16:01 |
|
Open: |
1.83 |
Pre. Close: |
1.8 |
|
High:
|
1.82 |
Low:
|
1.7 |
|
Volume:
|
91,244 |
Market Cap:
|
92(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:30:01 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 2.5 One year: 3.09 |
| Support: |
Support1: 1.33 Support2: 1.1 |
| Resistance: |
Resistance1: 2.14 Resistance2: 2.65 |
| Pivot: |
1.86  |
| Moving Average: |
MA(5): 1.91 MA(20): 1.99
MA(100): 2.22  MA(250): 2.07 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 53.1 %D(3): 55.3 |
| RSI: |
RSI(14): 39.4 |
| 52-week: |
High: 4.3 Low: 0.86 |
| Average Vol(K): |
3-Month: 183 (K) 10-Days: 267 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SONX ] has closed above bottom band by 43.7%. Bollinger Bands are 16.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.83 - 1.84 |
1.84 - 1.85 |
|
Low:
|
1.68 - 1.69 |
1.69 - 1.7 |
|
Close:
|
1.8 - 1.82 |
1.82 - 1.84 |
|
Company Description |
|
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California. |
Headline News |
Thu, 09 Mar 2023
Sonendo, Inc. (NYSE:SONX) Q4 2022 Earnings Call Transcript - Yahoo Finance
Wed, 08 Mar 2023
Sonendo, Inc. (SONX) Reports Q4 Loss, Tops Revenue Estimates - Zacks Investment Research
Wed, 08 Mar 2023
Sonendo, Inc Tops Q4 EPS by 9c By Investing.com - Investing.com UK
Tue, 07 Mar 2023
Sonendo, Inc.'s (NYSE:SONX) latest 14% decline adds to one-year losses, institutional investors may consider drastic measures - Simply Wall St
Mon, 06 Mar 2023
Sonendo Inc : A loss of 21 cents per share anticipated for ... - Kalkine Media
Sun, 05 Mar 2023
Masters Capital Management LLC Takes $428000 Position in ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
51 (M) |
| Shares Float |
32 (M) |
|
% Held by Insiders
|
16.3 (%) |
|
% Held by Institutions
|
65.9 (%) |
|
Shares Short
|
829 (K) |
|
Shares Short P.Month
|
1,070 (K) |
Stock Financials |
|
EPS
|
-1.64 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.63 |
|
Profit Margin (%)
|
-137 |
|
Operating Margin (%)
|
-139.8 |
|
Return on Assets (ttm)
|
-28.8 |
|
Return on Equity (ttm)
|
-74.1 |
|
Qtrly Rev. Growth
|
23.6 |
|
Gross Profit (p.s.)
|
0.2 |
|
Sales Per Share
|
0.82 |
|
EBITDA (p.s.)
|
-1.12 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-61 (M) |
|
Levered Free Cash Flow
|
-42 (M) |
Stock Valuations |
|
PE Ratio
|
-1.11 |
|
PEG Ratio
|
-0.1 |
|
Price to Book value
|
1.1 |
|
Price to Sales
|
2.2 |
|
Price to Cash Flow
|
-1.51 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
